Notice: Function WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /srv/wp.0033.co.uk/public/htdocs/wp-includes/functions.php on line 6121
Notice: Function WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /srv/wp.0033.co.uk/public/htdocs/wp-includes/functions.php on line 6121
Notice: Function WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /srv/wp.0033.co.uk/public/htdocs/wp-includes/functions.php on line 6121
Notice: Function WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /srv/wp.0033.co.uk/public/htdocs/wp-includes/functions.php on line 6121
Notice: Function WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /srv/wp.0033.co.uk/public/htdocs/wp-includes/functions.php on line 6121
Notice: Function WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /srv/wp.0033.co.uk/public/htdocs/wp-includes/functions.php on line 6121
Notice: Function WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /srv/wp.0033.co.uk/public/htdocs/wp-includes/functions.php on line 6121
Notice: Function WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /srv/wp.0033.co.uk/public/htdocs/wp-includes/functions.php on line 6121
Notice: Function WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /srv/wp.0033.co.uk/public/htdocs/wp-includes/functions.php on line 6121
Notice: Function WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /srv/wp.0033.co.uk/public/htdocs/wp-includes/functions.php on line 6121
This website is intended for healthcare professionals only
Roxane Hillier, EURETINA 2022: Mechanisms of action in rhegmatogenous retinal detachment repair (Part 2)
Warning: Undefined variable $authors in /srv/wp.0033.co.uk/public/htdocs/wp-content/themes/tmm/bth-templates/template_2024-single-media_gallery.php on line 201
Warning: Undefined variable $authors in /srv/wp.0033.co.uk/public/htdocs/wp-content/themes/tmm/bth-templates/template_2024-single-media_gallery.php on line 205
04:33 mins
Warning: Undefined variable $sponsored_single in /srv/wp.0033.co.uk/public/htdocs/wp-content/themes/tmm/bth-templates/template_2024-single-media_gallery.php on line 225
Warning: Undefined variable $sponsored_single in /srv/wp.0033.co.uk/public/htdocs/wp-content/themes/tmm/bth-templates/template_2024-single-media_gallery.php on line 495
Warning: Undefined variable $article_abstract in /srv/wp.0033.co.uk/public/htdocs/wp-content/themes/tmm/bth-templates/template_2024-single-media_gallery.php on line 509
In this touchOPHTHALMOLOGY interview, Roxane Hillier(Newcastle Eye Centre, Newcastle, UK) discussed techniques involved in retinal reattachment and shared the highlights from her EURETINA course on rhegmatogenous retinal detachment repair.
The instructional course entitled “Mechanisms of Action in Rhegmatogenous Retinal Detachment Repair” was conducted at EURETINA 2022, 1–4 September 2022
Could you tell us a little about the mechanisms of retinal reattachment with scleral buckle and pneumatic retinopexy? (00:13)
What modifications in techniques can improve the integrity of reattachment? (01:10)
What were the key take home messages of the course you presented at EURETINA? (03:19)
Disclosure:Roxane Hillierhas nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Warning: Trying to access array offset on null in /srv/wp.0033.co.uk/public/htdocs/wp-content/themes/tmm/bth-templates/template_2024-single-media_gallery.php on line 574
Warning: Trying to access array offset on null in /srv/wp.0033.co.uk/public/htdocs/wp-content/themes/tmm/bth-templates/template_2024-single-media_gallery.php on line 575
Warning: Trying to access array offset on null in /srv/wp.0033.co.uk/public/htdocs/wp-content/themes/tmm/bth-templates/template_2024-single-media_gallery.php on line 576
Register now for FREE access
Already registered? Login below.
Register Register
Login Login
Warning: Undefined variable $has_article_information in /srv/wp.0033.co.uk/public/htdocs/wp-content/themes/tmm/bth-templates/template_2024-single-media_gallery.php on line 630
Warning: Undefined variable $sponsored_single in /srv/wp.0033.co.uk/public/htdocs/wp-content/themes/tmm/bth-templates/template_2024-single-media_gallery.php on line 707
Arshad M Khanani, Roger Goldberg, Monica Loevestam-Adrian
NEW
At the ARVO 2026 Annual Meeting, DME remained a major focus, with multiple studies exploring how clinicians may extend treatment intervals, improve outcomes in suboptimal responders and target inflammatory pathways beyond VEGF. Across phase 2 and phase 3 trials, as well as real-world observational studies, key themes included long-term durability with faricimab, sustained-delivery approaches, and growing evidence supporting dual-pathway strategies that may help address the heterogeneity of DME in routine practice.
Advertisement
Warning: Undefined variable $sponsored_single in /srv/wp.0033.co.uk/public/htdocs/wp-content/themes/tmm/bth-templates/template_2024-single-media_gallery.php on line 1035
Designed for busy clinicians, these short, focused articles cut through theory to highlight what truly matters at the point of care including what works, what to watch for, and how to optimise outcomes in real-world settings.
The RESTORE trial (NCT04945772) is a phase 2b randomized, sham-controlled, multi-centre, multi-dose, double-masked clinical trial evaluating the efficacy and safety of MCO-010 optogenetic therapy in adults with retinitis pigmentosa. MCO-010 is an ambient-light activatable Multi-Characteristic Opsin (MCO) optogenetic therapy for ...
Retinitis pigmentosa is an inherited retinal dystrophy (IRD) caused by the loss of photoreceptors and characterized by retinal pigment deposits visible on fundus examination. Retinitis pigmentosa is the most common group of IRD. It was a pleasure to speak with ...
It was a pleasure to catch up with Dr Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA) about new and emerging neovascular age-related macular degeneration treatments, including the new anti-vascular endothelial growth factor which appear to lead to better outcomes ...
It was a pleasure to catch up with Dr Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA) about the problems with the clinical utility of vascular endothelial growth factor inhibitors and the issues around durability and ensuring good outcomes in ...
It was a pleasure to talk to Roxane Hillier (Newcastle Eye Centre, Newcastle, UK) on her EURETINA course on rhegmatogenous retinal detachment repair. In this interview, she discussed the treatment options for rhegmatogenous retinal detachment.
The instructional course entitled “Mechanisms ...
In this touchOPHTHALMOLOGY interview, Prof. Francesco Bandello (Department of Ophthalmology University Vita-Salute Scientific Institute San Raffaele, Milan, Italy) talks us through the advantages of optical coherence tomography angiography (OCTA) over conventional dye angiography in age-related macular degeneration (AMD) and a ...
In this touchOPHTHALMOLOGY interview, Prof. Francesco Bandello (Department of Ophthalmology University Vita-Salute Scientific Institute San Raffaele, Milan, Italy) discussed the findings of a study investigating the relationship between optical coherence tomography angiography and fluorescein angiography/indocyanine green angiography in AMD ...
Prof. Bart Leroy (Ghent University, Ghent, Belgium) joined touchOPHTHALMOLOGY in an interview to speak about RNA interference therapy and its advantages in treating inherited retinal diseases caused by CEP290 mutations.
‘RNA Interference Therapy for CEP290-IRD’ was presented at EURETINA 2022, 1–4 ...
The Archway study (NCT03677934) was a phase 3, randomized, active treatment–controlled trial for the treatment of nAMD, conducted at 77 study locations in the United States. We caught up with Prof. Usha Chakravarthy (Queen's University of Belfast, Belfast, Northern Ireland) to ...
In this interview on her EURETINA presentation, Prof. Kyoko Ohno-Matsui (Tokyo Medical and Dental University, Tokyo, Japan) discussed choroidal venous structures and how they change in myopic eyes.
‘Anomalies of choroidal venous structures in high myopia’ was presented at EURETINA 2022, 1–4 ...
Type 1 neovascularization can be a secondary feature of central serous chorioretinopathy. In this touchOPHTHALMOLOGY interview, Dr Dinah Zur (Center for Retinal Degenerations, Ophthalmology Division, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel) talks us through the implications of improper diagnosis of this ...
Login
Sign Up FREE
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Register now for FREE Access
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
